Page last updated: 2024-08-26

imipenem, anhydrous and Cardiovascular Diseases

imipenem, anhydrous has been researched along with Cardiovascular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bourra, B; Brun-Buisson, C; Gazaigne, L; Legrand, P; Lesprit, P; Renaud, B; Taillandier, E	1

Other Studies

1 other study(ies) available for imipenem, anhydrous and Cardiovascular Diseases

Article	Year
Campylobacter fetus bloodstream infection: risk factors and clinical features. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008, Volume: 27, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Campylobacter fetus; Campylobacter Infections; Cardiovascular Diseases; Diabetes Complications; Female; Humans; Imipenem; Immunocompromised Host; Male; Risk Factors; Treatment Outcome	2008

Article

Year

Campylobacter fetus bloodstream infection: risk factors and clinical features.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008, Volume: 27, Issue:3

Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Campylobacter fetus; Campylobacter Infections; Cardiovascular Diseases; Diabetes Complications; Female; Humans; Imipenem; Immunocompromised Host; Male; Risk Factors; Treatment Outcome

2008